Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19

pattismith

Senior Member
Messages
3,427
Likes
6,711
Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19 - ScienceDirect

https://doi.org/10.1016/j.clinph.2021.03.001

Highlights

First study applying TMS in patients with fatigue and dysexecutive syndrome in the aftermath of COVID-19.

TMS studies revealed marked impairment of GABAergic intracortical inhibitory circuits within primary motor cortex.

TMS may serve as diagnostic tool in cognitive disturbances and fatigue in post-COVID-19 patients.